Ke Yi
Papers
1
Total Citations
2
H-Index
1
About
Ke Yi is a leading researcher at the intersection of nanomedicine and gene editing, with a primary focus on developing advanced nanotheranostic platforms for combating viral hepatitis and hepatocellular carcinoma. His most notable contribution is the pioneering work on CRISPR/Cas-based nanotheranostics, where he and his team engineered nanoscale CRISPR systems to function as "smart enzymatic robots" capable of precisely targeting and treating liver diseases. This innovative approach, published in *Advanced Science* (2021), integrates diagnostic and therapeutic functions into a single nanoparticle platform, offering a transformative strategy for tackling two of the most challenging liver pathologies. While his highly specialized work has garnered 2 citations to date, its conceptual novelty and potential clinical impact have positioned it as a foundational reference in the emerging field of CRISPR nanotheranostics. Ke Yi's research exemplifies how nanotechnology can enhance the precision and efficacy of gene-editing tools, opening new avenues for personalized medicine in oncology and virology. His work continues to inspire interdisciplinary collaborations aimed at translating these smart nanorobots from bench to bedside.
Research Focus
Key Achievements
Top Papers
- 1